According to an American study, cells collected at the time of Covid-19 diagnosis can predict whether patients will go on to develop severe or mild forms of the disease.
Researchers from the Broad Institute at MIT and Harvard, and the Ragon Institute at Massachusetts General Hospital, studied samples of such cells.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!